BioSpace News Archive

Novartis research shows technology talent increasingly drawn to pharma industry since COVID-19, to solve healthcare challenges

Novartis revealed the healthcare and pharma industry has emerged as a desired career destination for tech talent during the COVID-19 pandemic, in the Powerful Pairing research report launched today.

June 25, 2020
·
8 min read
StageZero Life Sciences Announces Issuance of Receipt for Final Prospectus and Conditional Listing Approval

StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”) announces that it has today been issued a receipt by the Ontario Securities Commission in respect of its final prospectus dated June 22, 2020.

June 25, 2020
·
2 min read
Drug Development

Preclinical Study Demonstrating Symptomatic Relief of Diarrhea in Dogs Receiving Neratinib in Combination with Crofelemer (Mytesi) Presented at American Association for Cancer Research Virtual Annual Meeting

Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) announced today that a preclinical study evaluating the effects of crofelemer (Mytesi®) in providing symptomatic relief of diarrhea associated with the irreversible pan-HER tyrosine kinase inhibitor (TKI) neratinib (Nerlynx®) is being presented as an e-poster at the American Association for Cancer Research Virtual Annual Meeting II,

June 25, 2020
·
7 min read
STEMSATION(TM) EXPANDS CONSUMER REACH INTO $290 BILLION GLOBAL MARKET FOR NUTRACEUTICALS: Now Offering its Products in 30 Markets, in Four Currencies and Four Languages

StemSation International, Inc. (OTC PINK:STSN) - a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces its products are now available in 30 markets (the 27 EU markets, the UK, the US and Puerto Rico).

June 25, 2020
·
2 min read
BioMidwest

ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents

ENDRA Life Sciences Inc. (''ENDRA’’) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), has recently been issued Patents 10,682,059 and 10,687,789 from the United States Patent and Trademark Office.

June 25, 2020
·
4 min read
Drug Development

Kadmon Doses First Patient in Phase 1 Clinical Trial of KD033, an Anti-PD-L1/IL-15 Fusion Protein, in Adults with Metastatic or Locally Advanced Solid Tumors

Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a Phase 1 clinical trial evaluating KD033, an anti-PD-L1/IL-15 fusion protein, in patients with metastatic or locally advanced solid tumors.

June 25, 2020
·
6 min read
Ovation Science Expands its Distribution of DermSafe into Mexico to Assist in the Fight Against the Coronavirus (COVID-19)

Ovation Science Inc. (CSE:OVAT) (“Ovation” or the “Company”), announces it has expanded distribution of its DermSafe® hand sanitizer lotion to Mexico.

June 25, 2020
·
5 min read
Deals

Fusion Pharmaceuticals Announces Pricing of Initial Public Offering - June 26, 2020

Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced the pricing of its initial public offering of 12,500,000 common shares at a public offering price of $17.00 per share.

June 25, 2020
·
4 min read
FDA

FDA Approves FINTEPLA® (fenfluramine) for the Treatment of Seizures Associated with Dravet Syndrome

- FINTEPLA® significantly and substantially reduced convulsive seizure frequency in patients whose seizures were not adequately controlled on other medications, as observed in two phase 3 placebo-controlled clinical trials - Commercial launch planned for July 2020 - Zogenix to host an investor call tomorrow, June 26, at 8:30 AM ET / 5:30 AM PT [25-June-2020]

June 25, 2020
·
14 min read